ABSTRACT
Phalotris lemniscatus es la única especie representante del género Phalotris en Uruguay. Esta especie tiene una amplia distribución que incluye Uruguay, Rio Grande do Sul en Brasil y el norte de Argentina que se extiende a las áreas fronterizas con Bolivia y Paraguay. Aunque este ofidio no es agresivo, se registraron dos accidentes en Uruguay en los que se observó acción local y sistémica del veneno. Los mismos ocurrieron en las manos después de manipulación excesiva y prolongada de los ejemplares. Localmente presentaron edema leve, pero en términos sistémicos el veneno de Phalotris causó alteraciones en la coagulación. Los pacientes se recuperaron totalmente después de 3 días. Serán necesarios más estudios para establecer una terapia adecuada para los envenenamientos graves provocados por esta especie.
Phalotris lemniscatus is the only species representative of Phalotris genus in Uruguay. This species has a wide distribution that includes Uruguay, Rio Grande do Sul in Brazil and northern Argentina extending to the areas bordering Bolivia and Paraguay. Although this snake is not aggressive, there were two snakebite accidents in Uruguay. They occurred on the hands after excessive and prolonged handling of the specimens. Locally they showed mild edema, but in systemically Phalotris venom caused alterations in blood coagulation. The patients recovered completely after 3 days. More studies will be required to establish an adequate therapy for Phalotris severe envenomations.
Subject(s)
Humans , Male , Female , Adolescent , Middle Aged , Snake Bites/drug therapy , Snake Bites/blood , Snake Venoms/toxicity , Uruguay/epidemiologyABSTRACT
Antivenoms or antitoxins have been effectively used for more than a century. During this time, these products have always proven to be highly effective in the treatment of infections and envenomations. However, antivenoms did not exhibit good safety results in their initial applications. After many improvements, antivenoms have substantially better safety profiles but still have some side effects. Due to the occurrence of adverse reactions, the practice of using premedication with the intent to decrease side effects has become accepted or mandatory in many countries. The drugs used for premedication belong to the histamine H1 antagonist, glucocorticoid and catecholamine groups. Currently, this practice is being questioned due to low or controversial efficacies in clinical assays. In this article, we discuss the causes of adverse reactions, the mechanisms of drugs that block the undesired effects and the results obtained in clinical trials. Although these three families of drugs could have positive effects on reducing adverse reactions, only adrenaline has demonstrated positive results in clinical assays.
Subject(s)
Humans , Histamine Antagonists/therapeutic use , Antidotes/adverse effects , Drug-Related Side Effects and Adverse Reactions , Epinephrine/therapeutic use , Hydrocortisone/therapeutic use , Premedication , Poisoning/complicationsABSTRACT
Antivenoms or antitoxins have been effectively used for more than a century. During this time, these products have always proven to be highly effective in the treatment of infections and envenomations. However, antivenoms did not exhibit good safety results in their initial applications. After many improvements, antivenoms have substantially better safety profiles but still have some side effects. Due to the occurrence of adverse reactions, the practice of using premedication with the intent to decrease side effects has become accepted or mandatory in many countries. The drugs used for premedication belong to the histamine H1 antagonist, glucocorticoid and catecholamine groups. Currently, this practice is being questioned due to low or controversial efficacies in clinical assays. In this article, we discuss the causes of adverse reactions, the mechanisms of drugs that block the undesired effects and the results obtained in clinical trials. Although these three families of drugs could have positive effects on reducing adverse reactions, only adrenaline has demonstrated positive results in clinical assays.(AU)